
Researchers evaluate peer-reviewed literature on interventions to improve vaccine uptake among thousands of US adults studied between 2010 and 2015.
NACDS announces Mary Ann Wagner's retirement
Steven Anderson, president/CEO of NACDS, announced the retirement of Mary Ann Wagner, R.Ph., the association's senior VP of policy and pharmacy regulatory affairs, effective Dec. 31. Anderson expressed appreciation for the work that Wagner accomplished. She served NACDS members for 13 years, holding several positions before being promoted to her current position.
To see more Daily News articles,
To go to the Drug Topics homepage,






